日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenografts

GPC2-CAR T 细胞对原位髓母细胞瘤异种移植瘤具有强大的临床前活性

Okada, Reona; Fanuzzi, Mia; Rodriguez, Constanza; Oh, Jangsuk; Sreenivasan, Adhithi; Stack, Hannah G; Puebla, Mariela; Phadke, Ira; Cole, Allison P; Bradford, Shanshan; Kelly, Michael C; Lei, Haiyan; Ho, Mitchell; Cotter, Jennifer A; Thiele, Carol J; Zhang, Xiyuan; Nellan, Anandani; Nguyen, Rosa

Targeting Survivin: Now I Become Death, the Destroyer of Cells

目标锁定 Survivin:现在我化身为死神,细胞的毁灭者

Fanuzzi, Mia; Zheng, Shuhua; Horbinski, Craig M; Shaaban, Maryam A; Congivaram, Harrshavasan; Du, Ruochen; Tripathi, Shashwat; Hurley, Lisa; Kumthekar, Priya; Ahmed, Atique; Brat, Daniel J; Lesniak, Maciej S; Heimberger, Amy B

IMMU-21. B7-H3 NANOBODY CAR-T CELL THERAPY IN PEDIATRIC GLIOBLASTOMA

IMMU-21. B7-H3纳米抗体CAR-T细胞疗法治疗儿童胶质母细胞瘤

Tsang, Daniel Ping-Kuen; Matsushima, Toshinori; Adachi, Chihaya; Fanuzzi, Mia; Singh, Mohit Pratap; Puebla, Mariela; Cole, Allison; Li, Dan; Ho, Mitchell; Nellan, Anandani